Nishimura R, Shimada A, Abiru N, Matsuhisa M, Takahashi Y, Ikegami H. Association between glycemic control and patient-reported outcomes in adults with type 1 diabetes in Japan: the SAGE study subanalysis. Diabetol Int. 2023 (In press).
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM) ーReport from Committee of type 1 diabetes in Japan Diabetes Societyー. Diabetol Int. 2023 (In press)
Toyoda M, Murata T, Hirota Y, Hosoda K, Kato K, Kouyama K, Kouyama R, Kuroda A, Matoba Y, Matsuhisa M, Meguro S, Miura J, Nishimura K, Shimada A, Suzuki S, Tone A, Sakane N; ISCHIA Study Group. Possible Relationship between the Deteriorated Accuracy of Intermittent-Scanning Continuous Glucose Monitoring Device and the Contact Dermatitis: Post-hoc analysis of the ISCHIA Study. Tokai J Exp Clin Med. 2023 Sep 20;48(3):83-90.
Takenaka Y, Inoue I, Hirasaki M, Ikeda M, Kakinuma Y. Temporal inhibition of the electron transport chain attenuates stress-induced cellular senescence by prolonged disturbance of proteostasis in human fibroblasts. FEBS J. 2023 Aug;290(15):3843-3857.
Horii T, Oikawa Y, Shimada A, Mihara K. Real‐world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium–glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score‐matched model analysis in Japan. J Diabetes Investig. 2023 (In press).
Tamura Y, Kaga H, Abe Y, Yoshii H, Seino H, Hiyoshi T, Kuribayashi N, Inoue I, Watada H. Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study). Nutrients. 2023 Jun 24;15(13):2866.
Fukui T, Kobayashi T, Jimbo E, Aida K, Shimada A, Oikawa Y, Mori Y, Fujii T, Koyama R, Kobayashi K, Takeshita A, Yagihashi S. Bi-glandular and persistent enterovirus infection and distinct changes of the pancreas in slowly progressive type 1 diabetes mellitus. Sci Rep. 2023 Apr 28;13(1):6977.
Yasuda S, Suzuki S, Yanagisawa S, Morita H, Haisa A, Satomura A, Nakajima R, Oikawa Y, Inoue I, Shimada A. HLA typing of patients who developed subacute thyroiditis and Graves’ disease after SARS-CoV-2 vaccination: a case report. BMC Endocr Disord. 2023 Mar 7;23(1):54.
Kawasaki E, Shimada A, Imagawa A, Abiru N, Awata T, Oikawa Y, Osawa H, Kawabata Y, Kozawa J, Kobayashi T, Takahashi K, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kajio H, Hanafusa T, Ikegami H; Committee of type 1 diabetes, Japan Diabetes Society. Bivalent GAD autoantibody ELISA Improves clinical utility and risk prediction for adult autoimmune diabetes. J Diabetes Investig. 2023 Apr;14(4):570-581.
Yamanouchi Y, Inoue I, Goto S, Maruyama Y. Obesity, Atherosclerotic Risk Factors, and Metabolic Syndrome in Vascular Aging and Treatment in the Elderly. Health Evaluation and Promotion. 2023;50(4):403-411.
ISCHIA Study Group. Prevention of hypoglycemia by intermittent-scanning continuous glucose monitoring device combined with structured education in patients with type 1 diabetes mellitus: A randomized, crossover trial. Diabetes Res Clin Pract. 2023 Jan;195:110147.
Kawasaki E, Shimada A, Imagawa A, Abiru N, Awata T, Oikawa Y, Osawa H, Kawabata Y, Kozawa J, Kobayashi T, Takahashi K, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kajio H, Hanafusa T, Ikegami H; Committee of type 1 diabetes, Japan Diabetes Society. Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes. J Diabetes Investig. 2023 Jan;14(1):58-66.
Mizutani G*, Horii T*, Oikawa Y, Atsuda K, Shimada A. Real-world risk of lower-limb amputation associated with sodium–glucose cotransporter 2 inhibitors versus metformin: A propensity score-matched model analysis in Japan. J Diabetes Investig. 2022 Dec;13(12):2000-2009. * These authors contributed equally to this work.
Shimada A, Toda K, Inoue I, Yamada T, Oikawa Y. Combination of anti-CD25 antibody and poly I:C treatment in pregnant NOD mice may be used as “pregnancy-related” type 1 diabetes model. J Diabetes Investig. 2022 Sep;13(9):1489-1495.
Satomura A, Oikawa Y, Sato H, Takagi S, Yamashita T, Shimada A. A Patient with Ketosis-prone Type 2 Diabetes Showing Nearly Normalized Glucose Tolerance after Recovery from Severe Diabetic Ketoacidosis. Diabetol Int. 2022 Jul 28;14(1):109-113.
Yanagisawa S, Oikawa Y, Takagi S, Horikoshi Y, Satomura A, Imai K, Sakai J, Ishibashi N, Tarumoto N, Iida S, Nakayama H, Haga Y, Maesaki S, Shimada A. HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019. J Diabetes Investig. 2022 May;13(5):909-917.
Yamanouchi Y, Maeda K, Shinoda Y, Majima M, Lee J, Inoue I, Maruyama Y, Kurabayashi H. Can outpatient rehabilitation be continued during the COVID-19 pandemic? A report from a Japanese regional medical university hospital. Arch Rehabil Res Clin Transl. 2022 May 2:100199.
Satomura A, Oikawa Y, Haisa A, Suzuki S, Nakanishi S, Katsuki T, Shimada A. Clinical significance of insulin peptide-specific interferon-γ-related immune responses in ketosis-prone type 2 diabetes. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2124-e2132.
Oikawa Y, Hashimoto K, Hara K, Morimoto J, Namai K, Tanaka A, Tanaka S, Shimada A. Current clinical state of type 1 diabetes in Saitama prefecture. Diabetol Int. 2022 April 4;13(2):436-446.
Takenaka Y, Inoue I, Nakano T, Ikeda M, Kakinuma Y. Prolonged disturbance of proteostasis induces cellular senescence via temporal mitochondrial dysfunction and subsequent mitochondrial accumulation in human fibroblasts. FEBS J. 2022 Mar;289(6):1650-1667.
Takao T, Yanagisawa H, Suka M, Yoshida Y, Onishi Y, Tahara T, Kikuchi T, Kushiyama A, Anai M, Takahashi K, Wakabayashi Sugawa S, Yamazaki H, Kawazu S, Iwamoto Y, Noda M, Kasuga M. Synergistic association of the copper/zinc ratio under inflammatory conditions with diabetic kidney disease in patients with type 2 diabetes: The Asahi Diabetes Complications Study. J Diabetes Investig. 2022 Feb;13(2):299-307.
Horii T, Oikawa Y, Kunisada N, Shimada A, Atsuda K. Acute kidney injury in Japanese type 2 diabetes patients receiving sodium-glucose cotransporter 2 inhibitors: A nationwide cohort study. J Diabetes Investig. 2022 Jan;13(1):42-46.
Ikegami Y*, Takenaka Y*, Saito D, Shimada A, Inoue I. Anagliptin Monotherapy for Six Months in Patients With Type 2 Diabetes Mellitus and Hyper-Low-Density Lipoprotein Cholesterolemia Reduces Plasma Levels of Fasting Low-Density Lipoprotein Cholesterol and Lathosterol: A Single-Arm Intervention Trial. J Clin Med Res. 2021;13(10-11):502-509. (* These authors contributed equally to this work.)
Itoh D, Inoue K, Saito D, Hamaguchi K, Kaneko K, Sumita T, Inukai K, Inoue I, Shimada A. Effects of Dapagliflozin Compared with Sitagliptin and Metformin in Drug-Naïve Japanese Patients with Type 2 Diabetes: A 12-Week, Open-Label, Randomized, Active-Controlled Trial. Diabetes Ther. 2021 Dec;12(12):3201-3215.
Horii T*, Oikawa Y*, Atsuda K, Shimada A. On-label use of sodium-glucose cotransporter 2 inhibitors may increase the risk of diabetic ketoacidosis in patients with type 1 diabetes. J Diabetes Investig. 2021 Sep;12(9):1586-1593. (*: These authors contributed equally to this work.)
Nakano T, Aochi H, Masataka H, Takenaka Y, Fujita K, Tamura M, Soma H, Kamezawa H, Koizumi T, Shibuya H, Inomata R, Okuda A, Murakoshi T, Shimada A, Inoue I. Effects of Pparγ1 deletion on late-stage murine embryogenesis and cells that undergo endocycle. Dev Biol. 2021 Oct;478:222-235.
Chujo D, Imagawa A, Yasuda K, Abiru N, Awata T, Fukui T, Ikegami H, Kawasaki E, Katsuki T, Kobayashi T, Kozawa J, Nagasawa K, Ohtsu H, Oikawa Y, Osawa H, Shimada A, Shimoda M, Takahashi K, Tsuchiya K, Tsujimoto T, Yasuda H, Hanafusa T, Kajio H. Japanese Type 1 Diabetes Database Study (TIDE-J): rationale and study design. Diabetol Int. 2021 Sep 6;13(1):288-294.
Yasuda S, Inoue I, Shimada A. Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and Acromegaly. Intern Med. 2021;60(15):2451-2459.
Kurokawa Y, Oikawa Y, Shimada A, Yajima K. Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case report. Diabetol Int. 2021 Aug 10;13(1):300-303.
Sugawa SW, Yoshida Y, Hikima Y, Sato H, Shimada A, Noda M, Kushiyama A. Characteristics Associated with Early Worsening of Retinopathy in Patients with Type 2 Diabetes Diagnosed with Retinopathy at Their First Visit: A Retrospective Observational Study. J Diabetes Res. 2021 Jul 17;2021:7572326.
Kayamori Y, Nakamura M, Kishi K, Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H, Ai M, Tanaka A, Sumino H, Murakami M, Inoue I, Teramoto T, Yokoyama S. Comparison of the Japan Society of Clinical Chemistry reference method and CDC methodfor HDL and LDL cholesterol measurements using fresh sera. Pract Lab Med. 2021 May;25:e00228.